US politicians push to bring generic drug manufacturing back home.

Marco Rubio, RFK Jr., and Chris Klomp are pressuring pharmaceutical leaders to ramp up domestic production of generic medicines. This move aims to reduce reliance on foreign supply chains for essential drugs. The shift could impact drug availability and pricing for consumers.